agilon health, inc. Common Stock (AGL)
5.6800
+0.1800 (3.27%)
NYSE · Last Trade: Apr 13th, 3:00 AM EDT
Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
Via StockStory · April 10, 2025
Shares of healthcare services company Agilon Health (NYSE:AGL) jumped 29.9% in the afternoon session after Bernstein upgraded the stock's rating from Hold to Buy with a price target of $8.5. The firm noted that new data on AGL drove increased confidence in its turnaround plans and cash position.
Via StockStory · April 8, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · April 8, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · April 8, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · April 8, 2025
CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.
Via Benzinga · April 8, 2025
Via Benzinga · April 8, 2025
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · April 7, 2025
Via Benzinga · April 7, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services (NYSE:AMN) and its peers.
Via StockStory · April 2, 2025
Let’s dig into the relative performance of agilon health (NYSE:AGL) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
Via StockStory · April 2, 2025
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including McKesson (NYSE:MCK) and its peers.
Via StockStory · March 27, 2025
Via Benzinga · March 21, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Cardinal Health (NYSE:CAH) and the best and worst performers in the healthcare providers & services industry.
Via StockStory · March 21, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including Pediatrix Medical Group (NYSE:MD) and its peers.
Via StockStory · March 19, 2025
JP Morgan analyst updates estimates for Agilon Health, Inc. based on Q4 results and management's outlook for recovery and growth in 2025-2027.
Via Benzinga · March 18, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & services industry, including The Ensign Group (NASDAQ:ENSG) and its peers.
Via StockStory · March 13, 2025
Looking back on outpatient & specialty care stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including U.S. Physical Therapy (NYSE:USPH) and its peers.
Via StockStory · March 13, 2025

Growth is oxygen.
But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID cycle.
Via StockStory · March 12, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · February 26, 2025

Via Benzinga · February 26, 2025

Healthcare services company Agilon Health (NYSE:AGL) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.2% year on year to $1.52 billion. On the other hand, next quarter’s revenue guidance of $1.5 billion was less impressive, coming in 12% below analysts’ estimates. Its GAAP loss of $0.26 per share was 14.8% below analysts’ consensus estimates.
Via StockStory · February 25, 2025